Statistics
Publications
3
Citations
380
H-Index
3
Active since
2018
Affiliations
Alibaba Group (China)(Current)
Tinghui Zhu is an author at Alibaba Group (China) specializing in checkpoint inhibitor therapy, immune checkpoint inhibitors, and cancer immunotherapy.
Publications per year
2018–2024
3
3
A reappraisal of CTLA-4 checkpoint blockade in cancer immunotherapy
Xuexiang Du, Fei Tang, Mingyue Liu et al. · Cell Research · 2018 · 246 citations · Full text
Life Sciences, Immunology, Oncology +17
Immuno-PET Imaging of <sup>89</sup>Zr Labeled Anti-PD-L1 Domain Antibody
Dan Li, Siyuan Cheng, Sijuan Zou et al. · Molecular Pharmaceutics · 2018 · 122 citations
Pharmacy, Nuclear Medicine, Oncology +17
1–3 of 3